61-75 of 721
How ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
On the Frontlines of Metastatic Breast CancerHow ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
Exploring T-DXd in HER2-Positive Breast Cancer Treatment
On the Frontlines of Metastatic Breast CancerExploring T-DXd in HER2-Positive Breast Cancer Treatment
DESTINY-Breast11 and Neoadjuvant Care in HER2-Positive Breast Cancer
On the Frontlines of Metastatic Breast CancerDESTINY-Breast11 and Neoadjuvant Care in HER2-Positive Breast Cancer
Modern Approaches to Long-Term Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast CancerModern Approaches to Long-Term Metastatic Breast Cancer Care
New Insights into VKD: Exploring Maternal Obesity and Neonatal Vitamin K Status
Clinician's RoundtableNew Insights into VKD: Exploring Maternal Obesity and Neonatal Vitamin K Status
Preparing for Parenthood in Psoriasis: Closing Gaps in Family Planning Support
On the Frontlines of PsoriasisPreparing for Parenthood in Psoriasis: Closing Gaps in Family Planning Support
- advertisement
Evaluating PARP and ER Targeting in ER+/HER2– Breast Cancer
Project Oncology®Evaluating PARP and ER Targeting in ER+/HER2– Breast Cancer
From Resistance to Response: Evolving Treatment Pathways in HR+ Breast Cancer
Project Oncology®From Resistance to Response: Evolving Treatment Pathways in HR+ Breast Cancer
Tracking Tumor Resistance in Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast CancerTracking Tumor Resistance in Metastatic Breast Cancer Care
Advancing Endometrial Cancer Care: Molecular Targets and Emerging Therapies
Project Oncology®Advancing Endometrial Cancer Care: Molecular Targets and Emerging Therapies
Unmet Needs in Endometrial Cancer: Bridging Gaps in Treatment and Equity
Project Oncology®Unmet Needs in Endometrial Cancer: Bridging Gaps in Treatment and Equity
Reducing Endometrial Cancer Risk: Targeting Modifiable Risk Factors
Project Oncology®Reducing Endometrial Cancer Risk: Targeting Modifiable Risk Factors
- advertisement
Targeting Ribosome Maturation: A Preclinical Strategy for Triple-Negative Breast Cancer
Project Oncology®Targeting Ribosome Maturation: A Preclinical Strategy for Triple-Negative Breast Cancer
Modern Era, New Outcomes: Survival Trends in Breast Cancer Brain Metastases
Project Oncology®Modern Era, New Outcomes: Survival Trends in Breast Cancer Brain Metastases
The Future of Immunotherapy: Advancing Care in Endometrial Cancer
Project Oncology®The Future of Immunotherapy: Advancing Care in Endometrial Cancer























































